Cancer News and Research

Latest Cancer News and Research

Pay more than lip service to sun-screen advice for antihypertensive users

Users of common antihypertensive drugs, such as hydrochlorothiazide and nifedipine, may be at increased risk for developing lip cancer.

9 Aug 2012

Salvage surgery for oropharyngeal cancer needs due consideration

Japanese study results indicate a 5-year overall survival rate of 49% for oropharyngeal cancer patients treated with salvage surgery after initial treatment with chemoradiotherapy has failed.

9 Aug 2012

Patient cognition may affect EOL care intensity

Mild cognitive impairment in patients with advanced cancer may affect the intensity of end-of-life treatment and promote decision-making by caregivers, rather than patients, show US study results.

9 Aug 2012

Loyola to offer new radiotherapy system for cancer patients

A new radiotherapy system at Loyola University Medical Center will offer cancer patients shorter radiation treatments, with pinpoint accuracy and precision.

9 Aug 2012

Recurrences of ovarian cancer can be detected earlier and more accurately with PET/CT

Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, in certain cases, recurrences can be detected earlier and more accurately with PET or PET/CT than with conventional imaging techniques.

9 Aug 2012

Female voters are hot commodity for presidential candidates

On the campaign trail, President Barack Obama continues his efforts to shore up support among women voters, as GOP presidential hopeful Mitt Romney vies for working-class voters.

9 Aug 2012

Herceptin® could potentially be delivered via a standard injection

A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published Online First in The Lancet Oncology.

9 Aug 2012

Syrians in urgent need of life-saving medicines as fighting escalates, WHO warns

"Syrians are in urgent need of life-saving medicines following an escalation in fighting, which also threatens further food shortages, U.N. agencies warned on Tuesday," Agence France-Presse reports.

9 Aug 2012

Study identifies a switch in cells that may help to kill tumors with heat

Research at Bangor University has identified a switch in cells that may help to kill tumors with heat. Prostate cancer and other localized tumors can be effectively treated by a combination of heat and an anti-cancer drug that damages the genes. Behind this novel therapy is the enigmatic ability of heat to switch off essential survival mechanisms in human cells. Although thermotherapy is now more widely used, the underlying principles are still unclear.

9 Aug 2012

Data from IMUC’s ICT-107 Phase I trial on glioblastoma multiforme accepted for publication

ImmunoCellular Therapeutics announced today that clinical data from its Phase I trial of ICT-107 was accepted for publication, and is currently in the online edition of the prestigious medical journal Cancer Immunology, Immunotherapy.

9 Aug 2012

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

9 Aug 2012

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

He sits at a kitchen table, nursing a cup of coffee, talking about what happened after Bain Capital closed down his steel plant in 2001. He lost his job; his family lost its health insurance. His wife felt lousy but didn't go to the doctor, to spare the family worry and expense. When she finally ended up in the hospital, the diagnosis was cancer. She had 22 days to live.

9 Aug 2012

Researchers develop and test new prostate cancer screening method

Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.

9 Aug 2012

MedPage Today, CollabRx sign license agreement for Oncology Next

Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

9 Aug 2012

Berlin Heart EXCOR Pediatric Ventricular Assist Device proves effective and life-saving

A tiny heart pump that maintains blood flow in babies and small children with serious heart failure proved effective and life-saving in a pioneering study involving 17 institutions led by Texas Children's Hospital and Baylor College of Medicine (BCM).

9 Aug 2012

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).

9 Aug 2012

Inaugural event of National Women's Survivors Convention to be held in Nashville

In August 2013, Nashville will be the host city to the National Women's Survivors Convention (NWSC), a first of its kind national event designed to celebrate women cancer survivors.

9 Aug 2012

VA agrees to move forward on CT screening for veterans at high risk for lung cancer

Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.

9 Aug 2012

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.

9 Aug 2012

VEGF inhibitor fails to improve nonsquamous NSCLC overall survival

Adding motesanib to carboplatin–paclitaxel does not boost overall survival in patients with advanced nonsquamous non-small-cell lung cancer, including those with adenocarcinoma, say MONET1 investigators.

8 Aug 2012

Cancer News and Research

Latest Cancer News and Research

Pay more than lip service to sun-screen advice for antihypertensive users

Salvage surgery for oropharyngeal cancer needs due consideration

Patient cognition may affect EOL care intensity

Loyola to offer new radiotherapy system for cancer patients

Recurrences of ovarian cancer can be detected earlier and more accurately with PET/CT

Female voters are hot commodity for presidential candidates

Herceptin® could potentially be delivered via a standard injection

Syrians in urgent need of life-saving medicines as fighting escalates, WHO warns

Study identifies a switch in cells that may help to kill tumors with heat

Data from IMUC’s ICT-107 Phase I trial on glioblastoma multiforme accepted for publication

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

Researchers develop and test new prostate cancer screening method

MedPage Today, CollabRx sign license agreement for Oncology Next

Berlin Heart EXCOR Pediatric Ventricular Assist Device proves effective and life-saving

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Inaugural event of National Women's Survivors Convention to be held in Nashville

VA agrees to move forward on CT screening for veterans at high risk for lung cancer

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

VEGF inhibitor fails to improve nonsquamous NSCLC overall survival

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in